Clinical Trial Update: Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial [Phase 2]

View source ↗

Summary

Phase 2 SAMURAI trial is evaluating the addition of stereotactic radiation therapy with immunotherapy for unresectable or metastatic renal cell carcinoma. The t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Snippet

Sponsor: NRG Oncology | Conditions: Metastatic Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8 | Phase 2 | Status: RECRUITING